Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes
NCT ID: NCT04899778
Last Updated: 2025-05-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
73 participants
INTERVENTIONAL
2021-09-29
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Hormonal Contraceptives on Incidence of ACL Injury Within Menstrual Cycle Phases
NCT04986267
The Influence of Oral Contraceptives During Disuse
NCT06275048
An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
NCT00344383
Assessing the Impact of Contraceptives on Bone Health Using 41Ca
NCT02367846
The Influence of Oral Contraceptive Use on Muscle Recovery
NCT04564300
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral Contraceptive Pill
Oral contraceptive, 1/day, for one year
Oral Contraceptive Pill, norethindrn a-e estradiol-iron
tablet
No Oral Contraceptive
No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral Contraceptive Pill, norethindrn a-e estradiol-iron
tablet
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older
* Currently playing basketball, soccer, or volleyball at Loyola Marymount or Pepperdine
* If not currently on COC, regular menstrual cycle occurring every 21-35 days
Exclusion Criteria
* Underlying neuromuscular disease
* Medical contraindication to COC use
* History of pregnancy
* Desire to conceive in the next year
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cedars-Sinai Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Natasha Trentacosta
Surgeon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cedars Sinai Medical Center
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00000922
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.